Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122948014 | 12294801 | 4 | F | 201602 | 20160821 | 20160422 | 20160829 | EXP | US-PFIZER INC-2016221538 | PFIZER | 70.00 | YR | M | Y | 75.00000 | KG | 20160829 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122948014 | 12294801 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG (CAPSULE), CYCLIC (ONCE A DAY FOR 4 WEEKS THEN 2 WEEKS OFF) | 2800 | MG | 21938 | 50 | MG | CAPSULE, HARD | |||||
| 122948014 | 12294801 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, 1X/DAY | 2800 | MG | 21938 | 50 | MG | CAPSULE, HARD | QD | |||||
| 122948014 | 12294801 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, 1X/DAY | 2800 | MG | 21938 | 50 | MG | CAPSULE, HARD | QD | |||||
| 122948014 | 12294801 | 4 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | QD | ||||||||
| 122948014 | 12294801 | 5 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 0.125 MG, 1X/DAY | 0 | .125 | MG | QD | |||||||
| 122948014 | 12294801 | 6 | C | WARFARIN | WARFARIN | 1 | 2.5 MG, 1X/DAY | 0 | 2.5 | MG | QD | ||||||||
| 122948014 | 12294801 | 7 | C | IRON | IRON | 1 | 1 DF, 2X/DAY (NON-PRESCRIPTION IRON PILL) | 0 | 1 | DF | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122948014 | 12294801 | 1 | Metastatic renal cell carcinoma |
| 122948014 | 12294801 | 4 | Blood cholesterol abnormal |
| 122948014 | 12294801 | 5 | Heart rate abnormal |
| 122948014 | 12294801 | 6 | Thrombosis |
| 122948014 | 12294801 | 7 | Blood iron abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122948014 | 12294801 | DE |
| 122948014 | 12294801 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122948014 | 12294801 | Abscess | |
| 122948014 | 12294801 | Asthenia | |
| 122948014 | 12294801 | Blood phosphorus increased | |
| 122948014 | 12294801 | Blood potassium increased | |
| 122948014 | 12294801 | Death | |
| 122948014 | 12294801 | Decreased appetite | |
| 122948014 | 12294801 | Diarrhoea | |
| 122948014 | 12294801 | Fatigue | |
| 122948014 | 12294801 | Gastrointestinal disorder | |
| 122948014 | 12294801 | Internal haemorrhage | |
| 122948014 | 12294801 | Pyrexia | |
| 122948014 | 12294801 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122948014 | 12294801 | 1 | 20160210 | 0 | ||
| 122948014 | 12294801 | 2 | 20160209 | 20160307 | 0 | |
| 122948014 | 12294801 | 3 | 20160404 | 20160501 | 0 | |
| 122948014 | 12294801 | 4 | 2016 | 0 | ||
| 122948014 | 12294801 | 5 | 201309 | 0 | ||
| 122948014 | 12294801 | 6 | 201508 | 0 | ||
| 122948014 | 12294801 | 7 | 201508 | 0 |